Included in the formulation
Included in the list (Order of the Government of the Russian Federation No. 2782-r of 30.12.2014):ONLS
VED
АТХ:V.06.D.D. Amino acids, including combinations with polypeptides
Pharmacodynamics:Combined drug.
Ketoanalogues of essential amino acids in the body with urea cleavage are converted into L-amino acid. It utilizes nitrogen-containing products of metabolism, improves nitrogen metabolism. Reduces the concentration in the blood plasma of magnesium, potassium, phosphate ions.
Pharmacokinetics:Not described.
Indications:It is used for the prevention and treatment of chronic renal failure.
IV.E40-E46.E46 Protein-energy insufficiency, unspecified
XIV.N17-N19.N18 Chronic Renal Failure
Contraindications:Disturbance of amino acid metabolism, hypercalcemia, age up to 3 years, pregnancy and lactation, individual intolerance.
Carefully:Hypersensitivity.
Pregnancy and lactation:Recommendations for FDA - Category C. Contraindicated in pregnancy and lactation.
Dosing and Administration:Use in children
Contraindicated up to 3 years of age.
Inside, 1 tablet for 5 kg of weight 1 time per day.
Adults
Inside, 4-8 tablets 3 times a day with meals.
The highest daily dose: 24 tablets.
The highest single dose: 8 tablets.
Side effects:Hypercalcemia.
Allergic reactions.
Overdose:Cases of overdose are not described.
Treatment is symptomatic.
Interaction:Possible development of hypercalcemia and hypophosphataemia when used simultaneously with antacid agents containing calcium or aluminum ions.
Special instructions:At the time of taking the drug, it is recommended to take high-calorie food.